Coral M. Stredny

Coral M. Stredny

Auto-generated profile, based on publicly available information

Coral M. Stredny

Neuroimmunology Center, Division of Epilepsy and Clinical Neurophysiology, Department of Neurology Boston Children's Hospital Boston Massachusetts USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Child Neurology Open
Verified
Journal Article
Open access
PDF file
CSCoral M. Stredny
Coral M. Stredny
SCSiobhan Case
Siobhan Case
ASArnold J. Sansevere
Arnold J. Sansevere
MSMaryBeth Son
MaryBeth Son
LHLauren Henderson
Lauren Henderson
MGMark P. Gorman
Mark P. Gorman
Febrile infection-related epilepsy syndrome (FIRES) is characterized by new onset refractory status epilepticus in a previously healthy child that is associated with poor cognitive outcomes and chronic epilepsy. Innate immune system dysfunction is hypothesized to be a key etiologic contributor, with a potential role for immunotherapy blocking pro-inflammatory cytokines, such as interleukin-1β and interleukin-6. We present a case of FIRES refractory to anakinra, an interleukin-1 receptor antagonist, subsequently treated with the ketogenic diet and tocilizumab, an interleukin-6 receptor antagonist, temporally associated with seizure cessation and a favorable 1-year outcome.

1 November 2017 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
MGMarina Gaínza-Lein
Marina Gaínza-Lein
RBRobert Benjamin
Robert Benjamin
CSCoral Stredny
Coral Stredny
MMMarlee McGurl
Marlee McGurl
KKKush Kapur
Kush Kapur
TLTobias Loddenkemper
Tobias Loddenkemper

1 May 2018 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
CSCoral M. Stredny
Coral M. Stredny
NANicholas S. Abend
Nicholas S. Abend
TLTobias Loddenkemper
Tobias Loddenkemper

1 May 2019 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
SJSaba Jafarpour
Saba Jafarpour
CSCoral M. Stredny
Coral M. Stredny
JPJuan Piantino
Juan Piantino
KCKevin E. Chapman
Kevin E. Chapman

31 March 2022 in International Journal of Integrated Care
Verified
Journal Article
Open access
PDF file
MJMichele C. Jackson
Michele C. Jackson
AVAlejandra Vasquez
Alejandra Vasquez
OOOLUWAFEMI OJO
OLUWAFEMI OJO
AFAlexandra Fialkow
Alexandra Fialkow
SHSarah Hammond
Sarah Hammond
TLTobias Loddenkemper
Tobias Loddenkemper
We aimed to describe the acute seizure care pathway for pediatric patients and identify barriers encountered by those involved in seizure care management. We also proposed interventions to bridge these care gaps within this pathway. We constructed a process map that illustrates the acute seizure care pathway for pediatric patients at Boston Children’s Hospital (BCH). The map was designed from knowledge gathered from unstructured interviews with experts at BCH, direct observation of patient care management at BCH through a quality improvement implemented seizure diary and from findings through three studies conducted at BCH, including a prospective observational study by the pediatric Status Epilepticus Research Group, a multi-site international consortium. We also reviewed the literature highlighting gaps and strategies in seizure care management. Within the process map, we identified twenty-nine care gaps encountered by caregivers, care teams, residential and educational institutions, and proposed interventions to address these challenges. The process map outlines clinical care of a patient through the following settings: 1) pre-hospitalization setting, defined as residential and educational settings before hospital admission, 2) BCH emergency department and inpatient settings, 3) post-hospitalization setting, defined as residential and educational settings following hospital discharge or clinic visit and 4) follow-up BCH outpatient settings, including neurology, epilepsy, and primary care provider clinics. The acute seizure care pathway for a pediatric patient who presents with seizures exhibits at least twenty-nine challenges in acute seizure care management. Identification of care barriers in the acute seizure care pathway provides a necessary first step for implementing interventions and strategies in acute seizure care management that could potentially impact patient outcomes.

18 January 2025 in Epilepsia
Verified
Journal Article
Open access
PEPoul H. Espino
Poul H. Espino
KEKrista Eschbach
Krista Eschbach
LBLeah J. Blank
Leah J. Blank
MCMackenzie Cervenka
Mackenzie Cervenka
EMEyal Muscal
Eyal Muscal
TGTeneille E. Gofton
Teneille E. Gofton
We propose and prioritize important outcome domains that should be considered for future research investigating long‐term outcomes (LTO) after new onset refractory status epilepticus (NORSE). The study was led by the international NORSE Institute LTO Working Group. First, literature describing the LTO of NORSE survivors was identified using a PubMed search and summarized to identify knowledge gaps. Subsequently, a consensus‐building process was performed to prioritize and rank important LTO domains for further research. The prioritization of LTO domains was qualitative, enabling the expert panel to generate ideas, share opinions, and provide reasons for the rankings. A second round took place to allow expansion and agreement regarding specific details for each domain. Outcomes were classified into eight main domains: (1) Function: Neuropsychological, Neurological (other than seizures), and Psychiatric (mood and behavior); (2) Quality of Life; (3) Epilepsy; (4) Nonneurological (medical); (5) Social; (6) Caregiver Burden; (7) Long‐Term Mortality; and (8) Health Care System Impact. In addition, the working group suggested obtaining outcome measures for each domain at 6 months and 1 year after discharge and annually thereafter until stability has been reached. There are no currently established time frames set for when LTO in NORSE begin or plateau, and previously there existed no consensus regarding which LTO should be considered. This consensus process identifies and recommends NORSE LTO domains that should be considered in future research studies to provide more consistent results that can be compared between studies. Survivors of NORSE should be evaluated serially and at fixed points over time to maximize our understanding of the recovery trajectory for all LTO domains. Establishing reliable and standardized data describing LTO (beyond seizures) after NORSE will support discussions with families during the acute stages, prognostication, the development of targeted management strategies for survivors, and future comparative research globally helping to identify biomarkers that may predict LTO.